Microbial Medical, Inc.
Our novel imaging and therapeutic agents target bacterial infection utilizing proprietary sugars as carriers to focus existing medical compounds on bacteria.
- Stage Product In Development
- Industry Biotechnology
- Location Atlanta, GA, US
- Currency USD
- Founded January 2015
- Employees 2
- Website microbialmedical.com
Company Summary
We are launching novel imaging agents and drugs for diagnosing and treating bacterial and fungal infections, based on a platform technology for chemically linking existing medical compounds with sugars that pathogens consume and human cells reject. Our initial products are contrast agents that enable common medical scanners to image infection and antibiotics that address antibiotic resistance and have reduced toxicity.
Team
-
CFO
Over 20 years experience serving in executive management, entrepreneurial and management consulting roles, including McKinsey & Company
Has founded or co-founded multiple entrepreneurial ventures, and served over 6 years as COO and CFO of QSpex Technologies, a VC-funded life sciences company
MBA from Columbia Business School and a BBA (Honors) from The University of Georgia -
Michael WachCEO
Repeat entrepreneur
Raised > $20M in VC
Intellectual property expertise
Expertise in in vivo molecular imaging
Coulter Innovation and Entrepreneurship Award
51 issued US patents
BEE & MSEE, Ga. Tech.; Innovation & Entrepreneurship Program, Stanford University
Advisors
-
Board Member
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.